Den danske medicinalgigant Novo Nordisk har sendt sit populære slankemiddel Wegovy ind på et af verdens største ...

While Novo Nordisk’s CEO Lars Fruergaard Jørgensen has defended the high U.S. prices of the company’s blockbuster drugs, ...

The headline trial results will be closely monitored by pharmaceutical industry experts. Shares in Novo Nordisk, which ...

Dit smart-tv, din mobiltelefon og sågar også din bil kan fortælle historier om dig, som du ikke har lyst til at dele – men her stopper det ikke Etik på TV 2 ...

Lars Fruergaard Jørgensen betegnes af magasinet Fortune som den 29. mest magtfulde erhvervsleder i verden. Novo Nordisks ...

PhRMA's “Middleman” and “Your Insurance” characters snatch savings away from a bewildered patient.

Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. International ...

Lars Fruergaard Jørgensen began his career at Novo Nordisk as an economist in the health care, economy, and planning ...

“Honestly, I’m quite alarmed by what we see in the U.S. now,” Novo Nordisk President and CEO Lars Fruergaard Jorgensen told CNN on Wednesday. “Patients who believe that they’re getting access to a ...

Compounded versions of semaglutide, the active ingredient in approved diabetes and obesity drugs Ozempic and Wegovy, have ...

They are expected to act as a catalyst in medicine, society, the economy, and even in... fuel consumption - The astounding ...

A day after the warning landed on semaglutide labels, Novo Nordisk CEO Lars Fruergaard Jørgensen said he is alarmed by the amount of unsafe compounded GLP-1s in the U.S. market, adding that the ...